- Home
- MDT
MDT
Medtronic plc.
as 09-04-2025 4:00pm EST
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.
| Founded: | 1949 | Country: | Ireland |
| Employees: | N/A | City: | GALWAY |
| Market Cap: | 114.9B | IPO Year: | N/A |
| Target Price: | $102.62 | AVG Volume (30 days): | 7.3M |
| Analyst Decision: | Buy | Number of Analysts: | 15 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 3.62 | EPS Growth: | 21.95 |
| 52 Week Low/High: | $79.29 - $96.25 | Next Earning Date: | 08-19-2025 |
| Revenue: | $34,200,000,000 | Revenue Growth: | 4.98% |
| Revenue Growth (this year): | 7.58% | Revenue Growth (next year): | 5.40% |
Stock Insider Trading Activity of Medtronic plc. (MDT)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Jellison William R | MDT | N/A | Aug 25 '25 | Buy | $92.37 | 2,500 | $230,925.00 | 5,000 | |
| Jellison William R | MDT | N/A | Aug 22 '25 | Buy | $92.73 | 2,500 | $231,825.00 | 5,000 |
Latest Medtronic plc. News
MDT Breaking Stock News: Dive into MDT Ticker-Specific Updates for Smart Investing
GlobeNewswire
12 hours ago
Insights Into the $50+ Billion Urology Care Devices & Platforms Market 2025-2030 Featuring Boston Scientific, Olympus, Medtronic, Coloplast, and BD Among Other Industry Giants
Simply Wall St.
a day ago
Medtronic (MDT) Expands MiniMed System To Type 2 Diabetes With FDA Approvals
Simply Wall St.
a day ago
The Strong Earnings Posted By Medtronic (NYSE:MDT) Are A Good Indication Of The Strength Of The Business
Zacks
a day ago
ISRG's SP Stapler: A Game Changer for Colorectal and Thoracic Procedures?
MedTech Dive
2 days ago
Edwards, Medtronic and Abbott stand to benefit from new TAVR guidelines in Europe
Barchart
2 days ago
Medtronic Stock: Is MDT Outperforming the Healthcare Sector?
Insider Monkey
2 days ago
TD Cowen Affirms Buy Rating on Medtronic, Inc. (MDT) on RDN Therapy Prospects
MedTech Dive
2 days ago
Medtronic advances Abbott partnership with FDA nod
Compare MDT vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "MDT Medtronic plc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.